Member of the Association of American Physicians
Holger K. Eltzschig mainly investigates Adenosine, Hypoxia, Adenosine receptor, Inflammation and Molecular biology. Adenosine is a primary field of his research addressed under Internal medicine. His Hypoxia study combines topics in areas such as Signal transduction, Cell biology and Vascular permeability.
His Inflammation study contributes to a more complete understanding of Immunology. His Immunology research is multidisciplinary, incorporating elements of mir-223 and Receptor. The study incorporates disciplines such as Ex vivo, CD18, Integrin alpha M, Gene expression and Regulation of gene expression in addition to Molecular biology.
His primary scientific interests are in Adenosine, Internal medicine, Inflammation, Adenosine receptor and Immunology. His Adenosine study integrates concerns from other disciplines, such as Adenosine A3 receptor, Hypoxia, Cell biology, Adenosine A2B receptor and Pharmacology. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Cardiology.
His work deals with themes such as Cancer research, Lung injury and Intestinal mucosa, which intersect with Inflammation. Holger K. Eltzschig has included themes like Extracellular, Signal transduction and 5'-nucleotidase in his Adenosine receptor study. His work carried out in the field of Immunology brings together such families of science as Receptor and Inflammatory bowel disease.
His primary areas of investigation include Lung injury, Hypoxia, Inflammation, Adenosine and Cancer research. His study in Hypoxia is interdisciplinary in nature, drawing from both Liver transplantation, Cytokine, Liver injury, Signal transduction and Kidney. His Inflammation research is included under the broader classification of Immunology.
The study incorporates disciplines such as mir-223 and Inflammatory bowel disease in addition to Immunology. His Adenosine study incorporates themes from Adenosine A2B receptor, Adenosine receptor, Cell biology, Reperfusion injury and Pharmacology. He frequently studies issues relating to Extracellular and Adenosine receptor.
The scientist’s investigation covers issues in Inflammation, Immunology, Hypoxia, Adenosine and mir-223. His studies in Inflammation integrate themes in fields like Extracellular matrix, Lung and Cytokine. His Immunology research is multidisciplinary, incorporating perspectives in Lung injury and Inflammatory bowel disease.
Holger K. Eltzschig interconnects Adenosine A2B receptor, Cancer research, Signal transduction and Kidney in the investigation of issues within Hypoxia. As part of the same scientific family, he usually focuses on Kidney, concentrating on Ischemia and intersecting with Intensive care medicine. His Adenosine research includes elements of Purinergic signalling, Adenosine receptor, Cell biology, Interleukin and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ischemia and reperfusion—from mechanism to translation
Holger K Eltzschig;Tobias Eckle.
Nature Medicine (2011)
Hypoxia and Inflammation
Holger K Eltzschig;Peter Carmeliet.
The New England Journal of Medicine (2011)
Adenosine receptors as drug targets — what are the challenges?
Jiang-Fan Chen;Holger K. Eltzschig;Bertil B. Fredholm.
Nature Reviews Drug Discovery (2013)
Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia
Kristin Synnestvedt;Glenn T. Furuta;Katrina M. Comerford;Nancy Louis.
Journal of Clinical Investigation (2002)
Nucleotide signalling during inflammation
Marco Idzko;Davide Ferrari;Holger K. Eltzschig.
Nature (2014)
Purinergic Signaling during Inflammation
Holger K. Eltzschig;Michail V. Sitkovsky;Simon C. Robson.
The New England Journal of Medicine (2012)
Crucial Role for Ecto-5′-Nucleotidase (CD73) in Vascular Leakage during Hypoxia
Linda F. Thompson;Holger K. Eltzschig;Juan C. Ibla;Juan C. Ibla;C. Justin Van De Wiele.
Journal of Experimental Medicine (2004)
Vascular ischaemia and reperfusion injury.
Holger K. Eltzschig;Charles D. Collard.
British Medical Bulletin (2004)
Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium Role of Ectonucleotidases and Adenosine A2B Receptors
Holger K. Eltzschig;Juan C. Ibla;Glenn T. Furuta;Martin O. Leonard.
Journal of Experimental Medicine (2003)
Hypoxia-Inducible Factor-1 Is Central to Cardioprotection A New Paradigm for Ischemic Preconditioning
Tobias Eckle;David Köhler;Rainer Lehmann;Karim C. El Kasmi.
Circulation (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas Health Science Center at Houston
University of Colorado Anschutz Medical Campus
The University of Texas Health Science Center at Houston
University of Colorado Denver
Beth Israel Deaconess Medical Center
Oklahoma Medical Research Foundation
University of Oxford
Boston University
University of Tübingen
University of Ferrara
University of South Australia
University of Maryland, College Park
Virginia Tech
Binghamton University
Ajou University
University of Western Ontario
University of Liverpool
European Bioinformatics Institute
University of Delaware
Ghent University
National Center for Atmospheric Research
Oregon State University
Federal University of Rio Grande do Sul
Hokkaido University
Université Catholique de Louvain
University of Michigan–Ann Arbor